デフォルト表紙
市場調査レポート
商品コード
1553660

禁煙および脱ニコチン依存症の市場規模、シェア、動向分析レポート:タイプ別、形態別、流通チャネル別、地域別、セグメント予測、2024年~2030年

Smoking Cessation And Nicotine De-addiction Market Size, Share & Trends Analysis Report By Type (Nicotine Replacement Therapy), By Form, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030


出版日
ページ情報
英文 100 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
禁煙および脱ニコチン依存症の市場規模、シェア、動向分析レポート:タイプ別、形態別、流通チャネル別、地域別、セグメント予測、2024年~2030年
出版日: 2024年08月28日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

禁煙および脱ニコチン依存症市場の成長と動向:

Grand View Research, Inc.の調査レポートによると、世界の禁煙および脱ニコチン依存症の市場規模は2030年までに509億米ドルに達し、2024年から2030年までのCAGRは10.4%で成長すると予測されています。

喫煙中毒人口は世界中で急速に増加しています。この人口層には主に10代と労働人口が含まれます。喫煙による死亡率は非常に高いです。禁煙願望の高まりと喫煙に伴う多くの健康合併症は、喫煙者の禁煙を支援する次世代ニコチンガムを発売したレボルマーのような、企業が斬新な禁煙製品を発売する強い動機となっています。このような改良された革新的なニコチン代替療法製品の発売は、禁煙および脱ニコチン依存症市場の成長にとってインパクトのある促進要因として機能することになります。

慢性閉塞性肺疾患(COPD)、喘息、心疾患、肺がんなどの対象疾患の罹患率の増加や、喫煙の有害な副作用に関する意識の高まりは、市場拡大を促進すると予想される要因です。教育機関は、喫煙の有害な影響や結果に関する情報を広めるために、さまざまなキャンペーンやプログラムを積極的に実施しており、若年層の意識を高めています。

禁煙および脱ニコチン依存症市場レポート・ハイライト

  • ニコチン置換療法(NRT)が2023年の禁煙および脱ニコチン依存症製品市場を独占しました。主に使用されるNRT製品には、ニコチンガムや経皮パッチが含まれます。入手しやすくなったことと、さまざまなフレーバーの摂取可能なニコチン製品のイントロダクションが、大きな市場シェアの要因となっています。
  • 電子タバコ分野は、予測期間中にCAGR 8.48%で成長すると予想されます。電子タバコ市場の成長の主な要因は、第2世代と第3世代の電子タバコのイントロダクション、様々なフレーバー製品の利用可能性、異なるブランド名で電子タバコを運営・販売する多数のベンダーの存在などです。
  • 2023年の禁煙および脱ニコチン依存症市場は、北米が40.3%の市場シェアを占めました。
  • アジア太平洋が最も急成長しています。中国、インド、オーストラリアなどの国々で、ニコチン禁煙製品と電子タバコが登録され、企業の流通チャネルが強化されていることが、予測期間中の成長を支えています。
  • 市場プレーヤーは、FDA承認ニコチン製品の市場開拓、商品化、流通に注力することで、電子タバコ市場でゆっくりと、しかし着実に進歩を遂げています。例えば、2014年にVictory Electronic Cigarettes Corporationは、販売チャネルを拡大し、より広い市場カバレッジを獲得する目的でTen Motives Ltd.を買収しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 禁煙および脱ニコチン依存症の市場変数、動向、範囲

  • 市場イントロダクション/系統展望
  • 市場規模と成長見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 禁煙および脱ニコチン依存症の市場分析ツール
    • ポーターの分析
    • PESTEL分析
    • 政治情勢
    • 経済と社会の情勢
    • 技術的情勢
    • 環境情勢
    • 法的な情勢

第4章 禁煙および脱ニコチン依存症市場:タイプ別推定・動向分析

  • セグメントダッシュボード
  • ニコチン置換療法
  • 薬物療法
  • 電子タバコ

第5章 禁煙および脱ニコチン依存症市場:形態タイプ別推定・動向分析

  • セグメントダッシュボード
  • 禁煙および脱ニコチン依存症市場:形態タイプ別変動分析、2023年および2030年
  • ガム
  • 吸入器
  • タブレット
  • その他

第6章 禁煙および脱ニコチン依存症市場:流通チャネルタイプ別推定・動向分析

  • セグメントダッシュボード
  • 禁煙および脱ニコチン依存症市場:流通チャネルタイプ別変動分析、2023年と2030年
  • 病院薬局
  • オンライン
  • ドラッグストアと薬局

第7章 禁煙および脱ニコチン依存症市場:地域別推定・動向分析

  • 禁煙および脱ニコチン依存症の市場シェア、地域別、2023年と2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東およびアフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 企業ヒートマップ分析
  • 企業プロファイル
    • Rusan Pharma Ltd
    • Dr. Reddy's Laboratories Ltd
    • Imperial Brands Plc
    • Zydus Group.
    • British American Tobacco Plc
    • Perrigo Company Plc
    • Johnson and Johnson Inc
    • NJOY, LLC
    • Cipla Ltd
    • GlaxoSmithKline Plc.
目次
Product Code: 978-1-68038-908-1

Smoking Cessation And Nicotine De-addiction Market Growth & Trends:

The global smoking cessation and nicotine de-addiction market size is expected to reach USD 50.90 billion by 2030, growing at a CAGR of 10.4% from 2024 to 2030, according to a report by Grand View Research, Inc. The base of population addicted to smoking is rapidly increasing across the globe. This population subset majorly includes teenagers and the working population. Smoking-related mortality is very high. The increasing desire to quit smoking and the numerous health complications associated with smoking serve as strong incentives for companies to introduce novel smoking cessation products, such as Revolymer, which has introduced the next generation nicotine gums to help smokers quit smoking. The launch of these improved and innovative nicotine replacement therapy products is to serve as a high impact rendering driver for the growth of the smoking cessation and nicotine de-addiction market.

The growing incidence of target diseases such as chronic obstructive pulmonary disease (COPD), asthma, cardiac diseases, and lung cancer, and the increasing awareness pertaining to the hazardous side-effects of smoking are the factors expected to promote market expansion. Educational institutions remain active in organizing various campaigns and programs to spread information about the harmful effects and consequences of smoking so as to increase young population awareness.

Smoking Cessation And Nicotine De-addiction Market Report Highlights:

  • Nicotine Replacement Therapy (NRT) dominated the smoking cessation and de-nicotine addiction product market in 2023. Majorly used NRT products include nicotine chewing gums and the transdermal patches. Increased availability and the introduction of the ingestible nicotine products with different flavors are the factors responsible for its large market share.
  • The e-cigarette segment is anticipated to grow at a CAGR of 8.48% over the forecast period. The major factors responsible for the growth of the E-cigarette market include the introduction of second and third generation e-cigarettes, the availability of various flavored products, the presence of numerous vendors operating and selling e-cigarettes under different brand names.
  • North America dominated the smoking cessation and nicotine de-addiction market with a market share of 40.3% in 2023.
  • Asia Pacific is the fastest growing market. The registration of nicotine de-addiction products and e-cigarettes as well as the strengthening of the company distribution channels in countries, such as China, India, and Australia are expected to support the growth over the forecast period.
  • The market players are making slow but steady progress in the e-cigarette market by focusing on the development, commercialization, and distribution of the FDA approved nicotine products. For instance, in 2014, Victory Electronic Cigarettes Corporation acquired Ten Motives Ltd. with an aim to expand their distribution channels and attain wider market coverage.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Smoking Cessation and Nicotine De-addiction Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Smoking Cessation and Nicotine De-addiction Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1 Bargaining power of the suppliers
      • 3.4.1.2 Bargaining power of the buyers
      • 3.4.1.3 Threats of substitution
      • 3.4.1.4 Threats from new entrants
      • 3.4.1.5 Competitive rivalry
    • 3.4.2. PESTEL Analysis
    • 3.4.3 Political landscape
    • 3.4.4 Economic and Social landscape
    • 3.4.5 Technological landscape
    • 3.4.6 Environmental landscape
    • 3.4.7 Legal landscape

Chapter 4. Smoking Cessation and Nicotine De-addiction Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Nicotine Replacement Therapy
    • 4.2.1. Nicotine Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2 Nicotine Lozenges
      • 4.2.2.1 Nicotine Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.3 Nicotine Gums
      • 4.2.3.1 Nicotine Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.4 Nicotine Sprays
      • 4.2.4.1 Nicotine Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.5 Nicotine Inhalers
  • 4.3. Drug Therapy
    • 4.3.1. Drug Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. E-cigarettes
    • 4.4.1. E-cigarettes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Smoking Cessation and Nicotine De-addiction Market: Form Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Smoking Cessation and Nicotine De-addiction Market: Form Type Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Gum
    • 5.3.1. Gum Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Inhalers
    • 5.4.1. Inhalers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Tablets
    • 5.5.1. Tablets Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Smoking Cessation and Nicotine De-addiction Market: Distribution Channel Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Smoking Cessation and Nicotine De-addiction Market: Distribution Channel Type Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Hospital Pharmacies
    • 6.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Online
    • 6.4.1. Online Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Drug stores and Retail Pharmacies
    • 6.5.1. Drug stores and Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Smoking Cessation and Nicotine De-addiction Market : Regional Estimates & Trend Analysis

  • 7.1. Smoking Cessation and Nicotine De-addiction Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1 U.S. Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1 Canada Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1 Mexico Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1 UK Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1 Germany Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1 France Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1 Italy Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1 Spain Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1 Denmark Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1 Sweden Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1 Norway Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1 Japan Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1 China Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1 India Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1 Australia Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1 South Korea Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1 Thailand Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1 Brazil Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1 Argentina Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1 South Africa Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1 Saudi Arabia Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1 UAE Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1 Kuwait Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Rusan Pharma Ltd
      • 8.4.1.1 Participant's Overview
      • 8.4.1.2 Financial Performance
      • 8.4.1.3 Product Benchmarking
      • 8.4.1.4 Recent Developments/ Strategic Initiatives
    • 8.4.2. Dr. Reddy's Laboratories Ltd
      • 8.4.2.1 Participant's Overview
      • 8.4.2.2 Financial Performance
      • 8.4.2.3 Product Benchmarking
      • 8.4.2.4 Recent Developments/ Strategic Initiatives
    • 8.4.3. Imperial Brands Plc
      • 8.4.3.1 Participant's Overview
      • 8.4.3.2 Financial Performance
      • 8.4.3.3 Product Benchmarking
      • 8.4.3.4 Recent Developments/ Strategic Initiatives
    • 8.4.4. Zydus Group.
      • 8.4.4.1 Participant's Overview
      • 8.4.4.2 Financial Performance
      • 8.4.4.3 Product Benchmarking
      • 8.4.4.4 Recent Developments/ Strategic Initiatives
    • 8.4.5. British American Tobacco Plc
      • 8.4.5.1 Participant's Overview
      • 8.4.5.2 Financial Performance
      • 8.4.5.3 Product Benchmarking
      • 8.4.5.4 Recent Developments/ Strategic Initiatives
    • 8.4.6. Perrigo Company Plc
      • 8.4.6.1 Participant's Overview
      • 8.4.6.2 Financial Performance
      • 8.4.6.3 Product Benchmarking
      • 8.4.6.4 Recent Developments/ Strategic Initiatives
    • 8.4.7. Johnson and Johnson Inc
      • 8.4.7.1 Participant's Overview
      • 8.4.7.2 Financial Performance
      • 8.4.7.3 Product Benchmarking
      • 8.4.7.4 Recent Developments/ Strategic Initiatives
    • 8.4.8. NJOY, LLC
      • 8.4.8.1 Participant's Overview
      • 8.4.8.2 Financial Performance
      • 8.4.8.3 Product Benchmarking
      • 8.4.8.4 Recent Developments/ Strategic Initiatives
    • 8.4.9. Cipla Ltd
      • 8.4.9.1 Participant's Overview
      • 8.4.9.2 Financial Performance
      • 8.4.9.3 Product Benchmarking
      • 8.4.9.4 Recent Developments/ Strategic Initiatives
    • 8.4.10. GlaxoSmithKline Plc.
      • 8.4.10.1 Participant's Overview
      • 8.4.10.2 Financial Performance
      • 8.4.10.3 Product Benchmarking
      • 8.4.10.4 Recent Developments/ Strategic Initiatives